Health Care
/
Eastern Norway

Nel Asa
BLOOD-BASED DIAGNOSIS THROUGH GENE EXPRESSION TECHNOLOGY

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenues: 6.301
    Operating profit: -37.133
    Operating profit before tax: -32.719
    Total assets: 1.457.625
    Total equity:1.451.226
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Hanne K Skaarberg Holen

    Board Members:
    Hanne K Skaarberg Holen
    Finn Marum Jebsen
    Mogens Filtenborg
    Ole Enger

    General Manager:
    Jon Andre Løkke

    Subsidiary companies:
    Largest shareholders:
    N/A
    Health Care, Health services, Research services,